OHSU sets fundraising record by meeting $1 billion challenge from Nike co-founder and wife
On Jun. 24, 2015, Oregon Health and Science University (OHSU) announced it had met Nike co-founder Phil Knight…
Sylvester Comprehensive Cancer Center was designated a Cancer Center of Excellence by the State of Florida
On Mar. 25, 2015, the Sylvester Comprehensive Cancer Center was designated a Cancer Center of Excellence by the…
Dendreon was acquired by Valeant Pharmaceuticals for $495 million
On Feb. 23, 2015, a bankruptcy judge approved the sale of the assets of Dendreon Corp., a Seattle-based…
Yale Cancer Center was awarded a SPORE grant for translational research in lung cancer
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
The Fred & Pamela Buffett Cancer Center announced recruitment of five leading cancer researchers
On Dec. 3, 2014, the Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center…
Ford Family Foundation awarded $5 million grant to advance the OHSU Knight Cancer Institute’s rural outreach
On Nov. 5, 2014, the Ford Family Foundation announced a $5 million grant to the Knight Cancer Institute…
Mary-Claire King received Lasker Foundation Award
On Sept. 8, 2014, the University of Washington and UW Medicine announced that Mary-Claire King, UW professor of…
Biotechnology | Diagnostics | Life Science News | Medicine | Non-Profit Research | Oncology | Therapeutics
University of Missouri School of Medicine received $2.4 million gift to funds endowed faculty chair in oncology
On Aug. 21, 2014, Mark McAndrew, a resident of McKinney, Texas, gave $2.4 million to the University of…
FDA approved Genentech’s Avastin plus chemotherapy for treatment of advanced cervical cancer
On Aug. 14. 2014, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Avastin (bevacizumab)…
Biotechnology | Diagnostics | Life Science News | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics
OHSU Knight Cancer Challenge announced $100 million gift
On Jul. 28, 2014, OHSU announced it has received a $100 million gift from an unnamed donor who…
Case Western Reserve University announced major philanthropic pledges
On Jun. 30, 2014, leaders from Case Western Reserve University and University Hospitals announced that Char and Chuck…
OHSU Collaborative Life Sciences Building launched new era in health and science research and education
On Jun. 26, 2014, OHSU announced completion of the Collaborative Life Sciences Building and Skourtes Tower, a next-generation…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Columbia Sportswear’s Tim and Mary Boyle announced a $10 million gift to OHSU Knight Cancer Institute
On Jun. 18, 2014, Columbia Sportswear President and CEO Tim Boyle and his wife, Mary, announced a donation…
Bezos family donated $20 million to the Fred Hutch to develop therapies that ‘melt’ cancer
On Apr. 7, 2014, the Fred Hutchinson Cancer Research Center announced that the Bezos family had committed $20…
Biotechnology | Diagnostics | Life Science News | Medicine | Non-Profit Research | Oncology | Therapeutics
Laura and Isaac Perlmutter donated $50 million to advance cancer research and treatment at NYU Langone Medical Center
On Jan. 29, 2014, NYU Langone Medical Center announced it had received an initial gift in excess of…
Siteman Cancer Center debuted the first single-vault proton therapy center in the country
On Dec. 19, 2013, the Siteman Cancer Center debuted the first single-vault proton therapy center in the U.S.:…
Genentech drug Gazyva (obinutuzumab) was approved
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute joined McLaren Health Care
On Oct. 30, 2013, the Karmanos Cancer Institute and McLaren Health Care signed an agreement that created the…
Nike co-founder Phil Knight and wife Penny issued $1 billion cancer challenge
On Sept. 21, 2013, philanthropists Phil and Penny Knight pledged $500 million to kick-start a $1 billion cancer…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
The Markey Cancer Center became an NCI-designated Cancer Center
On Jul. 12, 2013. the University of Kentucky Markey Cancer Center (MCC) was joined by national, state and…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
UNMC named new cancer center the Fred & Pamela Buffett Cancer Center
On Jun. 7, 2013, the University of Nebraska Board of Regents approved renaming the UNMC Eppley Cancer Center…
Biotechnology | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics | Women's Health
World Ovarian Cancer Day was established
On May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
Biotechnology | Diagnostics | Life Science News | Medicine | NIH | Non-Profit Research | Oncology | Therapeutics
The University of Kansas Cancer Center earned National Cancer Institute designation
On Jul. 12, 2012 the University of Kansas Cancer Center earned National Cancer Institute designation. Through efforts initially…
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
Report to the nation finds continuing declines in cancer death rates since the early 1990s
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On March 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Jan. 31, 2012, the U.S. Food and Drug Administration (FDA) granted Gleevec (imatinib) regular approval for use…